Tag: Steatohepatitis

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: CohBar, Inc. (NASDAQ: CWBR) Results from the Phase 1a/1b Study of CB4211

financial buzz08/11/2021

1864

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “CohBar, Inc. Rose 52% Following Positive Topline Results from the Phase 1a/1b Study of CB4211” CohBar, Inc (NASDAQ:...

Biotechnology Breaking News Healthcare Market News The Market Buzz

Breaking News: Algernon Pharmaceuticals Expands Its Research Program to Include Idiopathic Pulmonary Fibrosis

financial buzz02/25/201903/12/2019

4562

Algernon Pharmaceuticals Inc. (OTCQB: BTHCF) (CSE: AGN) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that based on positive preliminary data from its first...

Tag: Steatohepatitis

“The Buzz” Show: CohBar, Inc. (NASDAQ: CWBR) Results from the Phase 1a/1b Study of CB4211

Breaking News: Algernon Pharmaceuticals Expands Its Research Program to Include Idiopathic Pulmonary Fibrosis

ABOUT US

Tweets